Dr. Powles on Design and Findings of the BISCAY Trial in Platinum-Refractory Urothelial Cancer
October 31st 2019
Thomas Powles, MD, MBBS, MRCP, professor, Genitourinary Oncology, lead for Solid Tumour Research, and director, Barts Cancer Institute, discusses the design and findings of the phase Ib BISCAY trial in platinum-refractory urothelial cancer.